Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Randomized, Double-Blind, Phase III Study in India for Comparing Efficacy, Safety, and PK of ZRC-3277 (Pertuzumab Biosimilar) With Perjeta® in Patients With HER2-Positive Metastatic Breast Cancer.
Kothari R, Doshi M, Chaithanya PK, Ct S, Kumar A, Mallavarapu KM, Nagarkar R, Mahobia V, Bhatt N, Priyadarshini KL, Gogia A, Maksud T, Prasad S, Velavan K, L K R, Ss P, Talreja V, Kalra K, Nemade B, Dastidar AG, Gupta T, Patil T, Bondarde S, Patel P, Gupta S, Biswas G, Vaghela M, Mahato P, Parekh H, Kalloli M, Shetty R, Prakash G, Goel A, Mandal S, Choudhury T, Jain M, Goswami C, H M YK, Mukherjee KK, Shrivastava R, Parmar D. Kothari R, et al. Among authors: prasad s. Clin Breast Cancer. 2024 Oct;24(7):639-646.e2. doi: 10.1016/j.clbc.2024.07.001. Epub 2024 Jul 10. Clin Breast Cancer. 2024. PMID: 39069436 Clinical Trial.
Daratumumab in Indian patients with relapsed and refractory multiple myeloma: a prospective, multicenter, phase IV study.
Kumar L, Melinkeri S, Ganesan P, Kumar J, Biswas G, Kilara N, Pathalingappa H, Prasad S, Jain M, Mishra SK, Prasad S, Boyella PK, Sahoo RK, Bondarde S, Shah S, Rege M, Deb U, Korde T, Dixit J. Kumar L, et al. Among authors: prasad s. Future Oncol. 2024 Feb;20(4):191-205. doi: 10.2217/fon-2023-0842. Epub 2023 Dec 20. Future Oncol. 2024. PMID: 38116642 Clinical Trial.
3D RA vs 2D DSA in Brain Arteriovenous Malformations.
Singh V, Prasad SN. Singh V, et al. Among authors: prasad sn. Neurol India. 2024 Nov 1;72(6):1314-1315. doi: 10.4103/neuroindia.NI_910_20. Epub 2024 Dec 17. Neurol India. 2024. PMID: 39691024 Free article. No abstract available.
Risk Factors in Optimal Management of Hypertension in Elderly Patients Following 2017 American College of Cardiology-American Heart Association Guidelines.
Walder Z, Prasad S, Guevara A, Souedy AA, Martirosyan D, Moshman R, Porter A, Morris N, Khatiwala P, Thampi S, Hunter K, Roy S. Walder Z, et al. Among authors: prasad s. J Prim Care Community Health. 2024 Jan-Dec;15:21501319241306897. doi: 10.1177/21501319241306897. J Prim Care Community Health. 2024. PMID: 39676249 Free PMC article.
Diagnosis and management of dilated cardiomyopathy: a systematic review of clinical practice guidelines and recommendations.
Sorella A, Galanti K, Iezzi L, Gallina S, Mohammed SF, Sekhri N, Akhtar MM, Prasad SK, Chahal CAA, Ricci F, Khanji MY. Sorella A, et al. Among authors: prasad sk. Eur Heart J Qual Care Clin Outcomes. 2024 Dec 14:qcae109. doi: 10.1093/ehjqcco/qcae109. Online ahead of print. Eur Heart J Qual Care Clin Outcomes. 2024. PMID: 39674807
4,251 results